Alan J. Russell, Chief Scientific Officer at Edgewise Therapeutics, Inc. (EWTX), sold 5,901 shares at $43.68 ($258K) on 2026-08-12, disclosed to the SEC on 2026-08-14.
Open-market sale of $258k EWTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.68 | 2,273 | $99K | 38.5% |
| 2 | $43.68 | 3,238 | $141K | 54.8% |
| 3 | $44.46 | 390 | $17K | 6.7% |
| Total | $43.73 avg | 5,901 | $258K | 100% |
| Filing → |
| EWTX | SELL | 2025-08-28 | $1.5M | — | Filing → |
| EWTX | SELL | 2025-08-14 | $26K | — | Filing → |
| EWTX | SELL | 2025-05-07 | $26K | — | Filing → |